Viewing Study NCT06561360

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:16 AM
Ignite Modification Date: 2026-03-05 @ 11:54 AM
Study NCT ID: NCT06561360
Status: RECRUITING
Last Update Posted: 2025-10-07
First Post: 2024-08-13
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of Vemurafenib and Obinutuzumab Compared to Cladribine and Rituximab in People With Hairy Cell Leukemia (HCL)
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hairy Cell Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Vemurafenib View
None Obinutuzumab View
None Cladribine View
None Rituximab View
None 24-160 View